Job Detail

Laboratory Head - Molecular imaging/Radioligand Therapy (80-100%*)

Inseriert am: 24.05.2021

Back to Previous Page

Job ID 318683BR Position Title Laboratory Head - Molecular imaging/Radioligand Therapy (80-100%*) Apply to Job

Job Description

Applications are invited for a Laboratory Head position in Oncology Research that will carry out cutting-edge research in the areas of molecular imaging and radioisotope-based therapies together with leading basic research groups within NIBR. The candidate will be responsible for small animal molecular imaging (PET/SPECT/uCT) and drug discovery pharmacology activities within the Radioligand Therapy portfolio.



We seek an experienced, motivated and ambitious scientist wishing to continue a successful scientific career in a fast-paced drug discovery environment. The position is based at the Novartis Institutes of BioMedical Research (www.nibr.com) in Basel, Switzerland.



The ideal candidate should have a strong background in the molecular imaging modalities: PET, SPECT and uCT and a solid expertise and knowledge in developing Radioligand Therapies with a proven ability to conduct multidisciplinary research in a competitive field and an excellent record of achievements. The successful candidate will have solid expertise with rodent in vivo models and is expected to play a key role in the establishment of novel rodent models for Radioligand Therapies in the field of cancer.



Required skills and accountabilities:

• Lead a laboratory with expertise in nuclear medicine and innovative imaging modalities including PET/SPECT/uCT

• Perform biodistribution studies and metabolites analysis ex vivo

• Engage in independent research that will lead to innovative findings and novel fundamental insights

• Lead and manage cross-functional projects and external collaborations. Drive the project decision-making process, conceptualize and drive research projects to completion




Minimum requirements

Applicants should have a Ph.D. in medical physics, bioengineering, biotechnology, pharmacology or related field and at least 5 years of experience in a drug discovery setting. The position requires excellent communication skills in English and the motivation to work independently within a global team.



*Some restrictions on flexible working options may apply and will be discussed during interview if applicable.



Why consider Novartis?

799 million. That’s how many lives our products touched in 2019. And while we’re proud of that fact, in this world of digital and technological transformation, we must also ask ourselves this: how can we continue to improve and extend even more people’s lives?



We believe the answers are found when curious, courageous and collaborative people like you are brought together in an inspiring environment. Where you’re given opportunities to explore the power of digital and data. Where you’re empowered to risk failure by taking smart risks, and where you’re surrounded by people who share your determination to tackle the world’s toughest medical challenges.



Imagine what you could do at Novartis!



Commitment to Diversity & Inclusion:

Novartis embraces diversity, equal opportunity and inclusion. We are committed to building diverse teams, representative of the patients and communities we serve, and we strive to create an inclusive workplace that cultivates bold innovation through collaboration, and empowers our people to unleash their full potential.



Join our Novartis Network: If this role is not suitable to your experience or career goals but you wish to stay connected to learn more about Novartis and our career opportunities, join the Novartis Network here: talentnetwork.novartis.com/network Division NIBR Business Unit Oncology NIBR Location Switzerland Site Basel Company/Legal Entity Novartis Pharma AG Functional Area Research & Development Job Type Full Time Employment Type Regular Shift Work No

Apply to Job


Access Job Account





    • TwitterTweet

    • FacebookShare

    • Share

      • Twitter

      • Facebook

      • LinkedIn

      • Email

      • Whatsapp


    • Jump to Comments


  • Print

Details